Neurology Specific Literature Search   
 
[home][thesaurus]
    

Enter your terms
above and click
the 'Search' button.
Showing articles 0 to 31 of 31

Filter Applied: platelet inhibiting drugs (Click to remove)

Diagnosis and Management of the Antiphospholipid Syndrome
BMJ 340:1125-1132, Cohen,D., et al, 2010

Susac Syndrome
Medicine 77:3-11, Papo,T.,et al, 1998

Association of Cerebral Microbleeds with Mortality in Stroke Patients Having Atrial Fibrillation
Neurol 83:1308-1315,1304, Song, T.J.,et al, 2014

Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke
NEJM 368:1092-1100,1152, Carroll, J.D.,et al, 2013

Percutaneous Closure of Patent Foramen Ovale in Cryptogenic Embolism
NEJM 368:1083-1091,1152, Meier, B.,et al, 2013

Sporadic Cerebral Amyloid Angiopathy Revisited: Recent Insights Into Pathophysiology and Clinical Spectrum
JNNP 83:124-137, Charidimou,A.,et al, 2012

Effects of Clopidogrel Added to Aspirin in Patients with Recent Lacunar Stroke
NEJM 367:817-825, The SPS3 Investigators, 2012

Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
Stroke 42:227-276, Furie,K.L.,et al, 2011

Prior Antiplatelet Therapy and Outcome Following Intracerebral Hemorrhage
Neurol 75:1333-1342, 1314, Thompson,B.B.,et al, 2010

Study Design of the CLOSURE I Trial: A Prospective, Multicenter, Randomized, Controlled Trial to Evaluate the Safety and Efficacy of the STARFlex Septal Closure System Versus Best Medical Therapy in Patients With Stroke or TIA Due to Presumed Paradoxical Embolism Through a PFO
Stroke 41:2872-2883, Furlan,A.J.,et al, 2010

Moyamoya Disease and Moyamoya Syndrome
NEJM 360:1226-1237, Scott,R.M. &Smith,E.R., 2009

Regular Aspirin -Use Preceding the Onset of Primary Intracerebral Hemorrhage is an Independent Predictor for Death
Stroke 37:129-133,4, Saloheimo,P.,et al, 2006

Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack
Stroke 37:577-617, Sacco,R.L.,et al, 2006

Addition of Clopidogrel to Aspirin in 45852 Patients With Acute Myocardial Infarction: Randomised Placebo-Controlled Trial
Lancet 366:1607-1621, COMMIT (ClOpidogrel and Metoprolol in Myocardial Infarction Trial) collaborative group, 2005

Intracerebral Hemorrhage
The Neurologist 11:311-324, Badjatia,N. &Rosand,J., 2005

Clopidogrel-Associated TTP, An Update of Pharmacovigilance Efforts
Stroke 35:533-538, Zakarija,A.,et al, 2004

Aspriin and Clopidogrel Compared with Colpidogrel Alone After Recent Ischaemic Stroke or Transient Ischaemic Attack in High-Risk Patients (MATCH): Randomised, Double-Blind, Placebo-Controlled Trial
Lancet 364:331-337, Diener,H.-C.,et al, 2004

Anticoagulants and Antiplatelet Agents in Acute Ischemic Stroke
Neurol 59:13-22, Coull,B.M.,et al, 2002

Risk Factors for Visual Loss in Giant Cell (Temporal) Arteritis:A Prospective Study of 174 Patients
Am J Med 111:211-217, Liozohn,E.,et al, 2001

A Comparison of Warfarin and Aspirin for the Prevention of Recurrent Ischemic Stroke
NEJM 345:1444-1451,1493, Mohr,J.P.,et al, 2001

Stroke in Patients with Heart Failure and Reduced Left Ventricular Ejection Fraction
Neurol 54:288-294, Pullicini,P.M.,et al, 2000

Symptomatic Intracranial Atherosclerosis
Neurol 55:490-497, 465, Thijs,V.N. & Albers,G.W., 2000

Low-Dose and High-Dose Acetylsalicylic Acid for Patients Undergoing Carotid Endarterectomy:A Randomised Controlled Trial
Lancet 353:2179-2184,2172, Taylor,D.W.,et al, 1999

Thrombotic Thrombocytopenic Purpura Assoc with Ticlopidine, Review of 10 Cases
Ann Int Med 128:541-544, Bennett,C.L.,et al, 1998

CAST:Random Placebo-Controlled Trial of Early Aspirin Use in 20000 Pts with Acute Ischaemic Stroke
CAST Collab Grp, Lancet 349:1641-16491997., , 1997

Ticlopidine and Thrombotic Thrombocytopenic Purpura
NEJM 337:1245, Kupfer,Y.&Tessler,S., 1997

Ticlopidine for Prevention of Stroke
The Medical Letter, 34:65-661992., , 1992

A Critical Appraisal of Ticlopidine, A New Antiplat Agent, Effectiveness & Clin Indic for Prophylaxis
Arch Int Med 152:1376-1380, Haynes,R.B.,et al, 1992

The European Stroke Prevention Study:Results According to Sex
Neurol 41:1189-1192, Sivenius,J.,et al, 1991

Swedish Aspirin Low-Dose Trial (SALT) of 75 mg Aspirin as Secondary Prophylaxis After Cerebrovascular Ischaemic Events
The SALT Coll Group, Lancet 338:1345-13491991., , 1991

Medical Treatment of Transient Ischemic Attacks:Does it Influence Mortality
Stroke 19:397-400, Ramirez-Lassepas,M.&Cipolle,R.J., 1988



Showing articles 0 to 31 of 31